Cell Biology
CJC-1295 (ND) + Ipamorelin
Dual-Peptide Research Standard for GH Secretagogue & GHRH Receptor Studies
Ipamorelin / CJC-1295 (10 mg / 10 mg) is a dual-peptide research material intended exclusively for controlled laboratory and analytical research. Ipamorelin is a synthetic pentapeptide and ghrelin mimetic investigated for its interaction with the growth hormone secretagogue receptor (GHSR). Experimental research has demonstrated its ability to stimulate growth hormone release through GHSR-mediated signaling. CJC-1295 is a synthetic analog of growth hormone-releasing factor (GRF/GHRH) developed for investigation of GHRH receptor signaling and growth-hormone-related endocrine pathways. Published research has characterized CJC-1295 as a long-acting GRF analog. The combination provides researchers with two distinct peptide compounds for laboratory investigation of GHSR- and GHRH-associated signaling systems, receptor activity, peptide interactions, and related biochemical pathways. For laboratory research use only. Not for human or veterinary use. Not for consumption, administration, diagnostic use, or therapeutic use.
Frequently researched together
Other laboratory research compounds available in our catalog.
Compound information
Technical specifications
What is CJC-1295 (ND) + Ipamorelin?
CJC-1295 (ND) + Ipamorelin is a two-component research blend supplied as a single lyophilized preparation containing two distinct synthetic peptides in equal amounts, catalogued in 10 mg and 20 mg presentations. It is supplied strictly for laboratory research use and is not for human or veterinary use.
The first constituent, CJC-1295 without the drug affinity complex, is a synthetic analogue of growth hormone releasing hormone. Its chain corresponds to the 29-residue amino-terminal fragment written as GHRH(1-29) and carries four amino-acid substitutions relative to the native sequence, which is why it is described as a tetrasubstituted analogue. The letters ND mark the absence of the drug affinity complex modification. CJC-1295 is not stocked as a separate catalogue product.
The second constituent, ipamorelin, is a synthetic pentapeptide and ghrelin mimetic with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, built around a non-natural alpha-aminoisobutyric acid residue, two D-configuration residues and a carboxy-terminal amide. Ipamorelin is also stocked on its own, with identifiers and references on its catalogue page. Because the item is a blend rather than a single molecular entity, no combined CAS registry number, molecular formula or molecular weight is recorded for it, and none is stated here.
Stability information
Recommended handling and storage conditions for retaining compound identity and integrity in the laboratory.
Store lyophilized at −20°C, protected from light. Reconstitute and refrigerate (2–8°C) for short-term research use.
Regulatory information
Development origin and regulatory status, compiled for reference.
Research compound · Not FDA-approved
Frequently asked
Questions about CJC-1295 (ND) + Ipamorelin
What purity is CJC-1295 (ND) + Ipamorelin supplied at, and is a Certificate of Analysis available?
Yes. Each lot of CJC-1295 (ND) + Ipamorelin is tested by a third-party laboratory using HPLC for purity, and the certificate of analysis for the current lot is linked on this page and in the certificate library.
How is the identity of CJC-1295 (ND) + Ipamorelin verified?
Identity is confirmed by mass spectrometry against the expected molecular weight, alongside HPLC retention behaviour. Both results are recorded on the lot certificate.
How should CJC-1295 (ND) + Ipamorelin be stored on receipt?
Lyophilized material is stored at -20 C protected from light. Once reconstituted it is kept at 2 to 8 C for short-term laboratory use, and repeated freeze-thaw cycles are avoided.
Where is CJC-1295 (ND) + Ipamorelin shipped from?
Orders ship from the United States in discreet, tracked packaging. Shipping is available to US addresses only.
Is CJC-1295 (ND) + Ipamorelin supplied for research use only?
Yes. CJC-1295 (ND) + Ipamorelin is sold strictly as a laboratory research material. It is not for human or veterinary use, not for diagnostic procedures, and has not been evaluated by the U.S. Food and Drug Administration. See the research use disclaimer for the full terms.
Answers describe how this material is tested, stored and shipped. They are not guidance on any use, and this compound is not for human or veterinary use.
Sources & references
Published literature in which this compound has been the subject of laboratory or preclinical study. Listed for bibliographic reference only.
Research and educational purposes only. These references are provided for bibliographic context. They are not evidence of safety or efficacy, and nothing here is medical advice or a claim about any use in humans or animals.
Endocrinology
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog
Drug testing and analysis
Advances in the detection of growth hormone releasing hormone synthetic analogs